Premium
Manganese toxicity in the central nervous system: the glutamine/glutamate‐γ‐aminobutyric acid cycle
Author(s) -
SidorykWegrzynowicz M.,
Aschner M.
Publication year - 2013
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.12040
Subject(s) - toxicity , glutamine , glutamate receptor , medicine , central nervous system , manganese , citric acid cycle , pharmacology , biochemistry , endocrinology , metabolism , amino acid , biology , chemistry , receptor , organic chemistry
Manganese ( M n) is an essential trace element that is required for maintaining proper function and regulation of numerous biochemical and cellular reactions. Despite its essentiality, at excessive levels M n is toxic to the central nervous system ( CNS ). Increased accumulation of M n in specific brain regions, such as the substantia nigra, globus pallidus and striatum, triggers neurotoxicity resulting in a neurological brain disorder, termed manganism. M n has been also implicated in the pathophysiology of several other neurodegenerative diseases. Its toxicity is associated with disruption of the glutamine ( G ln)/glutamate ( G lu)‐γ‐aminobutyric acid ( GABA ) cycle ( GGC ) between astrocytes and neurons, thus leading to changes in G lu‐ergic and/or GABA ergic transmission and G ln metabolism. Here we discuss the common mechanisms underlying M n‐induced neurotoxicity and their relationship to CNS pathology and GGC impairment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom